Click for best price
Postpemic Era Pharmacokinetics Services Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Pharmacokinetics Services Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Pharmacokinetics Services industry at home and abroad, estimate the overall market scale of the Pharmacokinetics Services industry and the market share of major countries, Pharmacokinetics Services industry, and study and judge the downstream market demand of Pharmacokinetics Services through systematic research, Analyze the competition pattern of Pharmacokinetics Services, so as to help solve the pain points of various stakeholders in Pharmacokinetics Services industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Pharmacokinetics Services Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Pharmacokinetics Services Market?
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Major Type of Pharmacokinetics Services Covered in XYZResearch report:
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Application Segments Covered in XYZResearch Market
Small & Medium Enterprise
Large Enterprise
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Pharmacokinetics Services Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
98 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Pharmacokinetics Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pharmacokinetics Services Market by Value
2.2.1 Global Pharmacokinetics Services Revenue by Type
2.2.2 Global Pharmacokinetics Services Market by Value
2.3 Global Pharmacokinetics Services Market by Sales
2.3.1 Global Pharmacokinetics Services Sales by Type
2.3.2 Global Pharmacokinetics Services Market by Sales
3. The Major Driver of Pharmacokinetics Services Industry
3.1 Historical & Forecast Global Pharmacokinetics Services Sales and Revenue (2018-2028)
3.2 Largest Application for Pharmacokinetics Services (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Pharmacokinetics Services Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Pharmacokinetics Services Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Pharmacokinetics Services Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Pharmacokinetics Services Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Pharmacokinetics Services Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Pharmacokinetics Services Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Pharmacokinetics Services Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Pharmacokinetics Services Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Pharmacokinetics Services Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Pharmacokinetics Services Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Pharmacokinetics Services Average Price Trend
13.1 Market Price for Each Type of Pharmacokinetics Services in US (2018-2022)
13.2 Market Price for Each Type of Pharmacokinetics Services in Europe (2018-2022)
13.3 Market Price for Each Type of Pharmacokinetics Services in China (2018-2022)
13.4 Market Price for Each Type of Pharmacokinetics Services in Japan (2018-2022)
13.5 Market Price for Each Type of Pharmacokinetics Services in India (2018-2022)
13.6 Market Price for Each Type of Pharmacokinetics Services in Korea (2018-2022)
13.7 Market Price for Each Type of Pharmacokinetics Services in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Pharmacokinetics Services in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Pharmacokinetics Services Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Pharmacokinetics Services
15. Pharmacokinetics Services Competitive Landscape
15.1 Evotec AG (Germany)
15.1.1 Evotec AG (Germany) Company Profiles
15.1.2 Evotec AG (Germany) Product Introduction
15.1.3 Evotec AG (Germany) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Pacific BioLabs (US)
15.2.1 Pacific BioLabs (US) Company Profiles
15.2.2 Pacific BioLabs (US) Product Introduction
15.2.3 Pacific BioLabs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 GVK Biosciences Private Limited (India)
15.3.1 GVK Biosciences Private Limited (India) Company Profiles
15.3.2 GVK Biosciences Private Limited (India) Product Introduction
15.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Shanghai Medicilon Inc. (China)
15.4.1 Shanghai Medicilon Inc. (China) Company Profiles
15.4.2 Shanghai Medicilon Inc. (China) Product Introduction
15.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Pharmaceutical Product Development, LLC (US)
15.5.1 Pharmaceutical Product Development, LLC (US) Company Profiles
15.5.2 Pharmaceutical Product Development, LLC (US) Product Introduction
15.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Charles River Laboratories International, Inc. (US)
15.6.1 Charles River Laboratories International, Inc. (US) Company Profiles
15.6.2 Charles River Laboratories International, Inc. (US) Product Introduction
15.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 PAREXEL International Corporation (US)
15.7.1 PAREXEL International Corporation (US) Company Profiles
15.7.2 PAREXEL International Corporation (US) Product Introduction
15.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Eurofins Scientific, Inc. (Luxembourg)
15.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profiles
15.8.2 Eurofins Scientific, Inc. (Luxembourg) Product Introduction
15.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Frontage Labs (US)
15.9.1 Frontage Labs (US) Company Profiles
15.9.2 Frontage Labs (US) Product Introduction
15.9.3 Frontage Labs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 SGS SA (Switzerland)
15.10.1 SGS SA (Switzerland) Company Profiles
15.10.2 SGS SA (Switzerland) Product Introduction
15.10.3 SGS SA (Switzerland) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 LGC Limited (UK)
15.12 Creative Bioarray (US)
15.13 Certara, L.P. (Germany)
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Pharmacokinetics Services Industry (Volume)
Figure 2. Pharmacokinetics Services Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Pharmacokinetics Services Revenue in 2022
Figure 5. US Pharmacokinetics Services Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pharmacokinetics Services Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pharmacokinetics Services Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pharmacokinetics Services Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pharmacokinetics Services Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pharmacokinetics Services Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pharmacokinetics Services Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pharmacokinetics Services Revenue, by Type (Million USD) (2018-2028)
Table 4. Pharmacokinetics Services Sales, by Type (K Unit) (2018-2028)
Table 5. Pharmacokinetics Services Sales (K Unit) by Application (2018-2028)
Table 6. Pharmacokinetics Services Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Pharmacokinetics Services Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pharmacokinetics Services Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Pharmacokinetics Services in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Evotec AG (Germany) Profiles
Table 61. Evotec AG (Germany) Pharmacokinetics Services Product Introduction
Table 62. Evotec AG (Germany) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Evotec AG (Germany) Strategic initiatives
Table 64. Pacific BioLabs (US) Profiles
Table 65. Pacific BioLabs (US) Pharmacokinetics Services Product Introduction
Table 66. Pacific BioLabs (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Pacific BioLabs (US) Strategic initiatives
Table 68. GVK Biosciences Private Limited (India) Profiles
Table 69. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Introduction
Table 70. GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. GVK Biosciences Private Limited (India) Strategic initiatives
Table 72. Shanghai Medicilon Inc. (China) Profiles
Table 73. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Introduction
Table 74. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Shanghai Medicilon Inc. (China) Strategic initiatives
Table 76. Pharmaceutical Product Development, LLC (US) Profiles
Table 77. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Introduction
Table 78. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Pharmaceutical Product Development, LLC (US) Strategic initiatives
Table 80. Charles River Laboratories International, Inc. (US) Profiles
Table 81. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Introduction
Table 82. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Charles River Laboratories International, Inc. (US) Strategic initiatives
Table 84. PAREXEL International Corporation (US) Profiles
Table 85. PAREXEL International Corporation (US) Pharmacokinetics Services Product Introduction
Table 86. PAREXEL International Corporation (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. PAREXEL International Corporation (US) Strategic initiatives
Table 88. Eurofins Scientific, Inc. (Luxembourg) Profiles
Table 89. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Introduction
Table 90. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Eurofins Scientific, Inc. (Luxembourg) Strategic initiatives
Table 92. Frontage Labs (US) Profiles
Table 93. Frontage Labs (US) Pharmacokinetics Services Product Introduction
Table 94. Frontage Labs (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Frontage Labs (US) Strategic initiatives
Table 97. SGS SA (Switzerland) Profiles
Table 98. SGS SA (Switzerland) Pharmacokinetics Services Product Introduction
Table 99. SGS SA (Switzerland) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. SGS SA (Switzerland) Strategic initiatives
Table 101. LGC Limited (UK) Profiles
Table 102. LGC Limited (UK) Pharmacokinetics Services Product Introduction
Table 103. LGC Limited (UK) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. LGC Limited (UK) Strategic initiatives
Table 105. Creative Bioarray (US) Profiles
Table 106. Creative Bioarray (US) Pharmacokinetics Services Product Introduction
Table 107. Creative Bioarray (US) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Creative Bioarray (US) Strategic initiatives
Table 109. Certara, L.P. (Germany) Profiles
Table 110. Certara, L.P. (Germany) Pharmacokinetics Services Product Introduction
Table 111. Certara, L.P. (Germany) Pharmacokinetics Services Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Certara, L.P. (Germany) Strategic initiatives
